Why Calumet Inc (CLMT) Stock Is Rising
As of 2026-11-12, Calumet Inc (CLMT) has a next-year EPS growth estimate of 346.21%. Featured in 4 EPS revision reports, most recently on 2026-08-17.
Why CLMT Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Calumet Inc's next-year EPS growth estimate from 229.45% to 248.32% on 2026-11-06.
- →Estimate Trending Higher: Since detection, the estimate has moved up a net +97.89 pp to 346.21% across 1 upward revision.
- !Largest Single-Day Revision: +97.89 pp on 2026-11-09 (248.32% → 346.21%).
- ·Current-Year Growth: Projected at -212.06%, supporting the forward estimate revision.
News Context
The primary structural driver has been the upward EPS estimate revision, with next-year EPS growth estimates raised from 229.45% to 248.32% on 2026-11-06. That upgrade plausibly connects to Calumet’s Q3 2026 results, which were described as a record quarter that crushed estimates, though management cautioned the specialty windfall may not be the new norm. Momentum has continued beyond the initial revision, with net EPS growth estimate changes of +97.89 pp across one
Generated 2026-11-11 · news as of 2026-11-10
Current Snapshot
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- EPS growth next year
- 346.21%
- EPS growth this year
- -212.06%
- EPS next quarter (est)
- $0.92
- Last price
- $36.45
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 346.21% | -212.06% | $0.92 | $36.45 |
| 2026-11-11 | 346.21% | -212.06% | $0.92 | $35.89 |
| 2026-11-10 | 346.21% | -212.06% | $0.92 | $34.91 |
| 2026-11-09 | 346.21% | -212.06% | $0.92 | $36.06 |
| 2026-11-07 | 248.32% | -391.03% | $0.90 | $39.64 |
| 2026-11-06 | 248.32% | -391.03% | $0.90 | $39.64 |
| 2026-11-05 | 229.45% | -430.52% | $1.63 | $43.35 |
| 2026-11-04 | 229.45% | -430.52% | $1.63 | $43.60 |
| 2026-11-03 | 229.45% | -430.52% | $1.63 | $47.33 |
| 2026-11-02 | 229.45% | -430.52% | $1.63 | $46.73 |
| 2026-10-31 | 229.45% | -430.52% | $1.63 | $49.65 |
| 2026-10-30 | 229.45% | -430.52% | $1.63 | $49.65 |
| 2026-10-29 | 229.45% | -430.52% | $1.63 | $48.53 |
| 2026-10-28 | 229.45% | -430.52% | $1.63 | $49.89 |
| 2026-10-27 | 229.45% | -430.52% | $1.63 | $49.89 |
| 2026-10-26 | 229.45% | -430.52% | $1.63 | $52.17 |
| 2026-10-23 | 229.45% | -430.52% | $1.63 | $49.31 |
| 2026-10-22 | 229.45% | -430.52% | $1.63 | $49.32 |
| 2026-10-21 | 229.45% | -430.52% | $1.63 | $52.59 |
| 2026-10-20 | 229.45% | -430.52% | $1.63 | $56.05 |
| 2026-10-19 | 229.45% | -430.52% | $1.63 | $55.54 |
| 2026-10-16 | 195.14% | -483.34% | $1.59 | $57.75 |
| 2026-10-15 | 195.14% | -483.34% | $1.59 | $58.24 |
| 2026-10-14 | 195.14% | -483.34% | $1.59 | $57.53 |
| 2026-10-13 | 195.14% | -483.34% | $1.59 | $58.59 |
| 2026-10-12 | 195.14% | -483.34% | $1.59 | $57.17 |
| 2026-10-11 | 195.14% | -483.34% | $1.59 | $56.42 |
| 2026-10-10 | 195.14% | -483.34% | $1.59 | $56.42 |
| 2026-10-09 | 195.14% | -483.34% | $1.59 | $56.42 |
| 2026-10-08 | 195.14% | -483.34% | $1.59 | $57.75 |
Reports Featuring CLMT
- 2026-08-17
SNDK Soars 45.9% After EPS Revision, AI Memory Boom Fuels Rally
- 2026-08-13
SHAZ Surges 44.6% on AI Capacity Expansion; SNDK, ACB, CLMT, NYXH Follow
- 2026-07-21
FWRD Leads EPS Revision Surge with 26.7% Gain; AEHR, RCEL Follow
- 2026-07-20
RCEL leads with 27.9% gain on EPS revision; other healthcare stocks follow
Recent News
- Calumet Crushes Estimates With Record Quarter, But Management Itself Warns The Specialty Windfall Is Not The New NormEarnings Whispers
- Calumet Crushes Estimates With Record Quarter, But Management Itself Warns The Specialty Windfall Is Not The New NormEarnings Whispers
- Calumet Reports Third Quarter 2026 ResultsPR Newswire
- Calumet Reports Third Quarter 2026 ResultsPR Newswire
- Calumet Upsizes Senior Secured Revolving Credit Facility and Receives Final $34 Million Draw under the DOE LoanPR Newswire
- Calumet Provides Update After Latest U.S. EPA Small Refinery Exemption DecisionPR Newswire
- Montana Renewables Announces Innovative, Capital-Efficient Expansion to 200 Million Gallons of Sustainable Aviation FuelPR Newswire
- Calumet Inc (CLMT) (Q2 2026) Earnings Call Highlights: Record Specialties Performance and ...GuruFocus.com
- Calumet Inc (CLMT) (Q2 2026) Earnings Call Highlights: Record Specialties Performance and ...GuruFocus.com
- Calumet Reports Second Quarter 2026 ResultsPR Newswire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Calumet Inc (CLMT) stock go up recently?▾
Calumet Inc (CLMT) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 229.45% to 248.32% on 2026-11-06. Since detection, the estimate has moved up a net +97.89 pp to 346.21%. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Calumet Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Calumet Inc (CLMT) has a next-year EPS growth estimate of 346.21%, based on analyst consensus.
When was the latest EPS estimate revision for CLMT?▾
The most recent revision occurred on 2026-11-09, when analysts adjusted the next-year EPS growth estimate from 248.32% to 346.21%.
What sector and industry does Calumet Inc belong to?▾
Calumet Inc operates in the Basic Materials sector, specifically the Specialty Chemicals industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CLMT appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Calumet Inc (CLMT) appears here because it was detected by our daily top-EPS-revision-performer screen.